•
Jun 30, 2023

Sera Prognostics Q2 2023 Earnings Report

Reported financial results for the second quarter of 2023.

Key Takeaways

Sera Prognostics reported second quarter 2023 revenue of $123,000, a net loss of $10.5 million, and cash, cash equivalents, and available-for-sale securities of approximately $92.1 million as of June 30, 2023.

Announced leadership changes and commercial actions in May 2023 to optimize business for market success.

Appointed Zhenya Lindgardt as interim President and CEO, and Austin Aerts as interim CFO.

Engaged leading strategy house to rigorously evaluate best pathways toward enhanced revenue at significant reduced cost.

Executed select headcount reductions in commercial organization to better map current commercial costs in line with refined focus.

Total Revenue
$123K
Previous year: $78K
+57.7%
EPS
-$0.34
Previous year: -$0.37
-8.1%
Gross Profit
$43K
Previous year: $22K
+95.5%
Cash and Equivalents
$32.3M
Previous year: $53.9M
-40.1%
Free Cash Flow
-$8M
Previous year: -$9.26M
-13.6%
Total Assets
$96.7M
Previous year: $125M
-22.7%

Sera Prognostics

Sera Prognostics

Forward Guidance

Sera Prognostics is pursuing a disciplined commercial approach to broaden adoption of their PreTRM® Test and evaluating ways to leverage their large and growing pregnancy datasets to boost shareholder value through new products and partnerships.